Only pyrimidinoceptors are functionally expressed in mouse neuroblastoma cell lines

Molecular Cell Biology Research Communications

Volumn 1, Issue 3, 1999, Pages 203-208

  Sak, Katrin ^a   Webb, Tania E ^b   Samuel, Külli ^c   Kelve, Merike ^c   Järv, Jaak ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c NATIONAL INSTITUTE OF CHEMICAL PHYSICS AND BIOPHYSICS   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; PURINE P2 RECEPTOR; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; HUMAN; METABOLISM; MOUSE; NEUROBLASTOMA; RAT;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; HUMANS; MICE; NEUROBLASTOMA; RATS; RECEPTORS, PURINERGIC P2; TUMOR CELLS, CULTURED; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE;

EID: 0033140051     PISSN: 15224724     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcbr.1999.0134     Document Type: Article

References (26)

1. Burnstock, G., and Wood, J. N. (1996) Curr. Opin. Neurobiol. 6, 526-532.
2. Seifert, R., and Schultz, G. (1989) Trends Pharmacol. Sci. 10, 365-369.
3. von Kugelgen, I., Spath, L., and Starke, K. (1994) Br. J. Pharmacol. 113, 815-822.
4. Boehm, S., Huck, S., and Illes, P. (1995) Br. J. Pharmacol. 116, 2341-2343.
5. von Kugelgen, I., Norenberg, W., Illes, P., Schobert, A., and Starke, K. (1997) Neuroscience 78, 935-941.
6. Barnard, E. A., Simon, J., and Webb, T. E. (1997)Mol. Neurobiol. 15, 103-129.
7. Nicholas, R. A., Watt, W. C., Lazarowski, E. R., Li, Q., and Harden, T. K. (1996) Mol. Pharmacol. 50, 224-229.
8. Webb, T. E., Henderson, D. J., Roberts, J. A., and Barnard, E. A. (1998) J. Neurochem. 71, 1348-1357.
9. Li, Q., Olesky, M., Palmer, R. K., Harden, T. K., and Nicholas, R. A. (1998) Mol. Pharmacol. 54, 541-546.
10. Lustig, K. D., Shiau, A. K., Brake, A. J., and Julius, D. (1993) Proc. Natl. Acad. Sci. USA 90, 5113-5117.
11. Chueh, S. H., and Kao, L. S. (1993) J. Neurochem. 61, 1782-1788.
12. Kaiho, H., Kimura, J., Matsuoka, I., Kumasaka, T., and Nakanishi, H. (1996) J. Neurochem. 67, 398-406.
13. Kaiho, H., Matsuoka, I., Kimura, J., and Nakanishi, H. (1998) J. Neurochem. 70, 951-957.
14. Webb, T. E., and Barnard, E. A. (1999) Prog. Brain Res. 120, 23-31.
15. Filippov, A. K., Webb, T. E., Barnard, E. A., and Brown, D. A. (1999) Br. J. Pharmacol. 126, 1009-1017.
16. Filippov, A. K., and Brown, D. A. (1996) Eur. J. Neurosci. 8, 1149-1155.
17. Palmer, R. K., Boyer, J. L., Schachter, J. B., Nicholas, R. A., and Harden, T. K. (1998) Mol. Pharmacol. 54, 1118-1123.
18. Mei, L., Roeske, W. R., and Yamamura, H. I. (1989) Brain Res. 504, 7-14.
19. Lambert, D. G., Challiss, R. A. J., and Nahorski, S. R. (1991) Biochem. J. 273, 791-794.
20. Thompson, A. K., and Fisher, S. K. (1991) J. Biol. Chem. 266, 5004-5010.
21. Fisher, S. K., Heacock, A. M., Seguin, E. B., and Agranoff, B. W. (1990) Mol. Pharmacol. 38, 54-63.
22. Chen, C. C., and Chen, W.-C. (1997) J. Neurochem. 69, 1409-1416.
23. Sak, K., Kelve, M., Uri, A., and Järv, J. (1998) FEBS Lett. 439, 107-109.
24. Lin, W. W. (1994) J. Neurochem. 62, 536-542.
25. Iredale, P. A., Martin, K. F., Alexander, S. P. H., Hill, S. J., and Kendall, D. A. (1992) Br. J. Pharmacol. 107, 1083-1087.
26. Boehm, S. (1998) Br. J. Pharmacol. 124, 1261-1269.